113 related articles for article (PubMed ID: 17336267)
1. Dynamic interplay between the neutral glycosphingolipid CD77/Gb3 and the therapeutic antibody target CD20 within the lipid bilayer of model B lymphoma cells.
Jarvis RM; Chamba A; Holder MJ; Challa A; Smith DC; Hodgkin MN; Lord JM; Gordon J
Biochem Biophys Res Commun; 2007 Apr; 355(4):944-9. PubMed ID: 17336267
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen.
Mangeney M; Lingwood CA; Taga S; Caillou B; Tursz T; Wiels J
Cancer Res; 1993 Nov; 53(21):5314-9. PubMed ID: 8221667
[TBL] [Abstract][Full Text] [Related]
3. CD40 ligand, Bcl-2, and Bcl-xL spare group I Burkitt lymphoma cells from CD77-directed killing via Verotoxin-1 B chain but fail to protect against the holotoxin.
Gordon J; Challa A; Levens JM; Gregory CD; Williams JM; Armitage RJ; Cook JP; Roberts LM; Lord JM
Cell Death Differ; 2000 Sep; 7(9):785-94. PubMed ID: 11042673
[TBL] [Abstract][Full Text] [Related]
4. Improved access to CD20 following B cell receptor cross-linking at Burkitt's lymphoma cell surfaces.
Holder MJ; Chamba A; Hardie DL; Deans JP; Gordon J
Leuk Res; 2004 Nov; 28(11):1197-202. PubMed ID: 15380345
[TBL] [Abstract][Full Text] [Related]
5. Two distinct Gb3/CD77 signaling pathways leading to apoptosis are triggered by anti-Gb3/CD77 mAb and verotoxin-1.
Tétaud C; Falguières T; Carlier K; Lécluse Y; Garibal J; Coulaud D; Busson P; Steffensen R; Clausen H; Johannes L; Wiels J
J Biol Chem; 2003 Nov; 278(46):45200-8. PubMed ID: 12944404
[TBL] [Abstract][Full Text] [Related]
6. MHC class II proteins contain a potential binding site for the verotoxin receptor glycolipid CD77.
George T; Boyd B; Price M; Lingwood C; Maloney M
Cell Mol Biol (Noisy-le-grand); 2001 Nov; 47(7):1179-85. PubMed ID: 11838965
[TBL] [Abstract][Full Text] [Related]
7. Comparison of adhesion mechanisms and surface protein expression in CD77-positive and CD77-negative Burkitt's lymphoma cells.
Jackson T; Van Exel C; Reagans K; Verret R; Maloney M
Cell Mol Biol (Noisy-le-grand); 2001 Nov; 47(7):1195-200. PubMed ID: 11838967
[TBL] [Abstract][Full Text] [Related]
8. Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells.
Maloney MD; Binnington-Boyd B; Lingwood CA
Glycoconj J; 1999 Dec; 16(12):821-8. PubMed ID: 11133022
[TBL] [Abstract][Full Text] [Related]
9. CD77-dependent retrograde transport of CD19 to the nuclear membrane: functional relationship between CD77 and CD19 during germinal center B-cell apoptosis.
Khine AA; Firtel M; Lingwood CA
J Cell Physiol; 1998 Aug; 176(2):281-92. PubMed ID: 9648915
[TBL] [Abstract][Full Text] [Related]
10. Globotriaosyl ceramide (CD77/Gb3) in the glycolipid-enriched membrane domain participates in B-cell receptor-mediated apoptosis by regulating lyn kinase activity in human B cells.
Mori T; Kiyokawa N; Katagiri YU; Taguchi T; Suzuki T; Sekino T; Sato N; Ohmi K; Nakajima H; Takeda T; Fujimoto J
Exp Hematol; 2000 Nov; 28(11):1260-8. PubMed ID: 11063874
[TBL] [Abstract][Full Text] [Related]
11. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes.
Rapoport AP; Simons-Evelyn M; Chen T; Sidell R; Luhowskyj S; Rosell K; Obrig T; Hicks D; Hinkle PM; Nahm M; Insel RA; Abboud CN
Blood Cells Mol Dis; 2001; 27(3):610-24. PubMed ID: 11482875
[TBL] [Abstract][Full Text] [Related]
12. CD77: an antigen of germinal center B cells entering apoptosis.
Mangeney M; Richard Y; Coulaud D; Tursz T; Wiels J
Eur J Immunol; 1991 May; 21(5):1131-40. PubMed ID: 1709864
[TBL] [Abstract][Full Text] [Related]
13. CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis.
Maloney MD; Lingwood CA
J Exp Med; 1994 Jul; 180(1):191-201. PubMed ID: 7516406
[TBL] [Abstract][Full Text] [Related]
14. Expression of differentiation and adhesion molecules in sporadic Burkitt's lymphoma.
Aiello A; Delia D; Fontanella E; Giardini R; Rilke F; Della Porta G
Hematol Oncol; 1990; 8(4):229-38. PubMed ID: 2210691
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways.
Mathas S; Rickers A; Bommert K; Dörken B; Mapara MY
Cancer Res; 2000 Dec; 60(24):7170-6. PubMed ID: 11156427
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD20 therapeutic antibody rituximab modifies the functional organization of rafts/microdomains of B lymphoma cells.
Semac I; Palomba C; Kulangara K; Klages N; van Echten-Deckert G; Borisch B; Hoessli DC
Cancer Res; 2003 Jan; 63(2):534-40. PubMed ID: 12543813
[TBL] [Abstract][Full Text] [Related]
17. Costimulatory signals distinctively affect CD20- and B-cell-antigen-receptor-mediated apoptosis in Burkitt's lymphoma/leukemia cells.
Mimori K; Kiyokawa N; Taguchi T; Suzuki T; Sekino T; Nakajima H; Saito M; Katagiri YU; Isoyama K; Yamada K; Matsuo Y; Fujimoto J
Leukemia; 2003 Jun; 17(6):1164-74. PubMed ID: 12764385
[TBL] [Abstract][Full Text] [Related]
18. CD20-induced B cell death can bypass mitochondria and caspase activation.
van der Kolk LE; Evers LM; Omene C; Lens SM; Lederman S; van Lier RA; van Oers MH; Eldering E
Leukemia; 2002 Sep; 16(9):1735-44. PubMed ID: 12200688
[TBL] [Abstract][Full Text] [Related]
19. A comparison of Verotoxin B-subunit (Stx1B) and CD77 antibody to define germinal centre populations.
Bailey S; Mardell C; Wheatland L; Zola H; Macardle PJ
Cell Immunol; 2005; 236(1-2):167-70. PubMed ID: 16165112
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol depletion inhibits src family kinase-dependent calcium mobilization and apoptosis induced by rituximab crosslinking.
Unruh TL; Li H; Mutch CM; Shariat N; Grigoriou L; Sanyal R; Brown CB; Deans JP
Immunology; 2005 Oct; 116(2):223-32. PubMed ID: 16162271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
